Literature DB >> 26138465

Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.

Daniel P Poole1, TinaMarie Lieu2, Juan Carlos Pelayo3, Emily M Eriksson4, Nicholas A Veldhuis5, Nigel W Bunnett6.   

Abstract

Activated G protein-coupled receptors traffic to endosomes and are sorted to recycling or degradative pathways. Endosomes are also a site of receptor signaling of sustained and pathophysiologically important processes, including inflammation. However, the mechanisms of endosomal sorting of receptors and the impact of disease on trafficking have not been fully defined. We examined the effects of inflammation on the subcellular distribution and trafficking of the substance P (SP) neurokinin 1 receptor (NK1R) in enteric neurons. We studied NK1R trafficking in enteric neurons of the mouse colon using immunofluorescence and confocal microscopy. The impact of inflammation was studied in IL10(-/-)-piroxicam and trinitrobenzenesulfonic acid colitis models. NK1R was localized to the plasma membrane of myenteric and submucosal neurons of the uninflamed colon. SP evoked NK1R endocytosis and recycling. Deletion of β-arrestin2, which associates with the activated NK1R, accelerated recycling. Inhibition of endothelin-converting enzyme-1 (ECE-1), which degrades endosomal SP, prevented recycling. Inflammation was associated with NK1R endocytosis in myenteric but not submucosal neurons. Whereas the NK1R in uninflamed neurons recycled within 60 min, NK1R recycling in inflamed neurons was delayed for >120 min, suggesting defective recycling machinery. Inflammation was associated with β-arrestin2 upregulation and ECE-1 downregulation, which may contribute to the defective NK1R recycling. We conclude that inflammation evokes redistribution of NK1R from the plasma membrane to endosomes of myenteric neurons through enhanced SP release and defective NK1R recycling. Defective recycling may be secondary to upregulation of β-arrestin2 and downregulation of ECE-1. Internalized NK1R may generate sustained proinflammatory signals that disrupt normal neuronal functions.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  G protein-coupled receptor; inflammatory bowel disease; tachykinin

Mesh:

Substances:

Year:  2015        PMID: 26138465      PMCID: PMC4537929          DOI: 10.1152/ajpgi.00118.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  56 in total

1.  Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation.

Authors:  J J Bowden; A M Garland; P Baluk; P Lefevre; E F Grady; S R Vigna; N W Bunnett; D M McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

2.  Detection of substance P in the central nervous system by a monoclonal antibody.

Authors:  A C Cuello; G Galfre; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

3.  The role of β-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract.

Authors:  Minho Kang; Hercules T Maguma; Tricia H Smith; Gracious R Ross; William L Dewey; Hamid I Akbarali
Journal:  J Pharmacol Exp Ther       Date:  2011-11-30       Impact factor: 4.030

4.  The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons.

Authors:  Matthias A Engel; Mohammad Khalil; Sonja M Mueller-Tribbensee; Christoph Becker; Winfried L Neuhuber; Markus F Neurath; Peter W Reeh
Journal:  J Gastroenterol       Date:  2011-11-12       Impact factor: 7.527

5.  Endothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neurones.

Authors:  Juan-Carlos Pelayo; Daniel P Poole; Martin Steinhoff; Graeme S Cottrell; Nigel W Bunnett
Journal:  J Physiol       Date:  2011-08-30       Impact factor: 5.182

6.  Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of corticotropin-releasing factor receptor 1 at high agonist concentrations.

Authors:  Burcu Hasdemir; Shilpi Mahajan; Nigel W Bunnett; Min Liao; Aditi Bhargava
Journal:  Mol Endocrinol       Date:  2012-02-09

7.  Neurokinin-1 and -3 receptor blockade inhibits slow excitatory synaptic transmission in myenteric neurons and reveals slow inhibitory input.

Authors:  P J Johnson; J C Bornstein
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  [RP 67580, a potent and selective substance P non-peptide antagonist].

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  C R Acad Sci III       Date:  1992

9.  β-Arrestin-1 deficiency protects mice from experimental colitis.

Authors:  Taehyung Lee; Eunhee Lee; Regina Irwin; Peter C Lucas; Laura R McCabe; Narayanan Parameswaran
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

10.  Conformational biosensors reveal GPCR signalling from endosomes.

Authors:  Roshanak Irannejad; Jin C Tomshine; Jon R Tomshine; Michael Chevalier; Jacob P Mahoney; Jan Steyaert; Søren G F Rasmussen; Roger K Sunahara; Hana El-Samad; Bo Huang; Mark von Zastrow
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

View more
  3 in total

Review 1.  Gene-environment interactions and the enteric nervous system: Neural plasticity and Hirschsprung disease prevention.

Authors:  Robert O Heuckeroth; Karl-Herbert Schäfer
Journal:  Dev Biol       Date:  2016-03-17       Impact factor: 3.582

2.  Inflammation-associated changes in DOR expression and function in the mouse colon.

Authors:  Jesse J DiCello; Ayame Saito; Pradeep Rajasekhar; Emily M Eriksson; Rachel M McQuade; Cameron J Nowell; Benjamin W Sebastian; Jakub Fichna; Nicholas A Veldhuis; Meritxell Canals; Nigel W Bunnett; Simona E Carbone; Daniel P Poole
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

3.  Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain.

Authors:  Jeffri S Retamal; Paulina D Ramírez-García; Priyank A Shenoy; Daniel P Poole; Nicholas A Veldhuis
Journal:  Front Mol Neurosci       Date:  2019-11-12       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.